1. Home
  2. DWSN vs MSLE Comparison

DWSN vs MSLE Comparison

Compare DWSN & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$4.26

Market Cap

124.5M

Sector

Energy

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.06

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DWSN
MSLE
Founded
1952
N/A
Country
United States
Canada
Employees
N/A
17
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
146.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
DWSN
MSLE
Price
$4.26
$6.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
107.3K
30.5K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.25
N/A
Revenue
$145,773,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$5.50
52 Week High
$5.54
$13.39

Technical Indicators

Market Signals
Indicator
DWSN
MSLE
Relative Strength Index (RSI) 58.94 38.58
Support Level $1.63 $5.50
Resistance Level $4.93 $8.59
Average True Range (ATR) 0.35 0.46
MACD -0.01 -0.12
Stochastic Oscillator 75.97 20.11

Price Performance

Historical Comparison
DWSN
MSLE

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: